News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
61 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (164)
2 (27)
3 (38)
4 (284)
5 (268)
6 (206)
7 (197)
8 (98)
9 (4)
10 (7)
11 (190)
12 (219)
13 (201)
14 (199)
15 (83)
16 (9)
17 (6)
18 (182)
19 (259)
20 (94)
21 (65)
22 (40)
23 (1)
24 (3)
25 (64)
26 (61)
27 (54)
28 (44)
29 (94)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Genetown
Acceleron to Present Preliminary Data on ACE-083 at the 2018 Annual Meeting of the Peripheral Nerve Society
Peripheral Nerve Society (PNS) annual meeting held in Baltimore, Maryland, July 22-25, 2018.
June 26, 2018
·
5 min read
Drug Development
New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce the Potential of The Medicines Company’s inclisiran in Patients with Diabetes
The data showed that a subcutaneous injection of 300 mg of inclisiran given at Day-1 and Day-90 lowered LDL-cholesterol (LDL-C) at Day-180 by more than 50% in patients with atherosclerotic cardiovascular disease (ASCVD) and those considered ASCVD-risk equivalents, regardless of whether those patients had diabetes.
June 26, 2018
·
4 min read
Drug Development
Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression
NV-5138 is a specific and direct activator of mTORC1, a cellular pathway required for the efficacy of many rapid acting antidepressants
June 26, 2018
·
6 min read
Biotech Beach
Pancreatic Cancer Action Network Funds Innovative Scientists through Research Grants Program
2018 Awards Contribute to PanCAN’s $48 Million Research Investment
June 26, 2018
·
2 min read
Business
AbbVie and Calico Announce Extension of Groundbreaking Collaboration
Extension builds on collaboration established in 2014
June 26, 2018
·
4 min read
Business
IsoPlexis Announces Research Collaboration with Nektar Therapeutics
Program will Aim to Further Characterize the Functional Impact of Nektar Immunotherapies
June 26, 2018
·
3 min read
Business
National Alliance of Healthcare Purchaser Coalitions and Remedy Partners Collaborate to Accelerate Healthcare Payment Reform
Integrated national platform aims to accelerate employer adoption of bundled payments
June 26, 2018
·
3 min read
Genetown
Aldeyra Therapeutics Announces Development Programs at 2018 Research Day
Expanded Pipeline Features Distinct Mechanisms of Action Across Five Product Candidates
June 26, 2018
·
6 min read
Business
Elligo Health Research and HealthiVibe Partner to Deliver Patient Insights
Elligo Health Research has partnered with HealthiVibe. The goal of the partnership is to bring the patient to the center of the clinical trial experience.
June 26, 2018
·
3 min read
BioMidwest
Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock
Aerpio will begin trading on the Nasdaq Capital Market under the symbol “ARPO” at the opening of trading on June 26, 2018
June 26, 2018
·
3 min read
Previous
3 of 7
Next